Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Heart rate reduction: an old and novel candidate heart failure therapy.

Ma Y, Chilton RJ, Lindsey ML.

Hypertension. 2012 May;59(5):908-10. doi: 10.1161/HYPERTENSIONAHA.111.186494. No abstract available.

2.

Role of heart rate reduction in the prevention of experimental heart failure: comparison between If-channel blockade and β-receptor blockade.

Becher PM, Lindner D, Miteva K, Savvatis K, Zietsch C, Schmack B, Van Linthout S, Westermann D, Schultheiss HP, Tschöpe C.

Hypertension. 2012 May;59(5):949-57. doi: 10.1161/HYPERTENSIONAHA.111.183913.

3.

Aldosterone antagonism as an antiarrhythmic approach for atrial arrhythmias in heart failure.

Ram R, Van Wagoner DR.

J Cardiovasc Electrophysiol. 2006 May;17(5):542-3. No abstract available.

PMID:
16684030
4.

Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure.

De Ferrari GM, Mazzuero A, Agnesina L, Bertoletti A, Lettino M, Campana C, Schwartz PJ, Tavazzi L.

Eur J Heart Fail. 2008 Jun;10(6):550-5. doi: 10.1016/j.ejheart.2008.04.005.

5.

Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure.

Milliez P, Messaoudi S, Nehme J, Rodriguez C, Samuel JL, Delcayre C.

Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H435-41. doi: 10.1152/ajpheart.00591.2008.

6.

Effects of metoprolol in chagasic patients with severe congestive heart failure.

Dávila DF, Angel F, Arata de Bellabarba G, Donis JH.

Int J Cardiol. 2002 Oct;85(2-3):255-60.

PMID:
12208592
7.

Metoprolol CR/XL improves systolic and diastolic left ventricular function in patients with chronic heart failure.

Hole T, Frøland G, Gullestad L, Offstad J, Skjaerpe T.

Echocardiography. 2004 Apr;21(3):215-23.

PMID:
15053783
8.

Heart rate and heart failure. Not a simple relationship.

Heusch G.

Circ J. 2011;75(2):229-36. Review.

9.

Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).

Ghali JK, Piña IL, Gottlieb SS, Deedwania PC, Wikstrand JC; MERIT-HF Study Group..

Circulation. 2002 Apr 2;105(13):1585-91.

10.

Lessons from the BEAUTIfUL trial.

[No authors listed]

Cardiovasc J Afr. 2009 Jul-Aug;20(4):261-2. No abstract available.

11.

Effects of ivabradine and metoprolol on cardiac angiogenesis and endothelial dysfunction in rats with heart failure.

Ulu N, Henning RH, Goris M, Schoemaker RG, van Gilst WH.

J Cardiovasc Pharmacol. 2009 Jan;53(1):9-17. doi: 10.1097/FJC.0b013e318193dfce.

PMID:
19129742
12.

Chronic administration of oral vasopressin type 2 receptor antagonist tolvaptan exerts both myocardial and renal protective effects in rats with hypertensive heart failure.

Morooka H, Iwanaga Y, Tamaki Y, Takase T, Akahoshi Y, Nakano Y, Fujiki H, Miyazaki S.

Circ Heart Fail. 2012 Jul 1;5(4):484-92. doi: 10.1161/CIRCHEARTFAILURE.111.965392.

13.
15.

Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.

Kobayashi M, Machida N, Mitsuishi M, Yamane Y.

Am J Hypertens. 2004 Dec;17(12 Pt 1):1112-9.

PMID:
15607617
16.

Heart rate reduction induced by the if current inhibitor ivabradine improves diastolic function and attenuates cardiac tissue hypoxia.

Fang Y, Debunne M, Vercauteren M, Brakenhielm E, Richard V, Lallemand F, Henry JP, Mulder P, Thuillez C.

J Cardiovasc Pharmacol. 2012 Mar;59(3):260-7. doi: 10.1097/FJC.0b013e31823e5e01.

PMID:
22075752
17.

Metoprolol CR/XL in patients with heart failure: A pilot study examining the tolerability, safety, and effect on left ventricular ejection fraction.

Goldstein S, Kennedy HL, Hall C, Anderson JL, Gheorghiade M, Gottlieb S, Jessup M, Karlsberg RP, Friday G, Haskell L.

Am Heart J. 1999 Dec;138(6 Pt 1):1158-65.

PMID:
10577448
18.

Single dose ivabradine versus intravenous metoprolol for heart rate reduction before coronary computed tomography angiography (CCTA) in patients receiving long-term calcium channel-blocker therapy.

Celik O, Atasoy MM, Ertürk M, Yalçın AA, Aksu HU, Diker M, Aktürk IF, Atasoy I.

Acta Radiol. 2014 Jul;55(6):676-81. doi: 10.1177/0284185113505276.

PMID:
24052362
19.

Β-adrenergic blockade combined with subcutaneous B-type natriuretic peptide: a promising approach to reduce ventricular arrhythmia in heart failure?

Thireau J, Karam S, Roberge S, Roussel J, Aimond F, Cassan C, Gac A, Babuty D, Le Guennec JY, Lacampagne A, Fauconnier J, Richard S.

Heart. 2014 Jun;100(11):833-41. doi: 10.1136/heartjnl-2013-305167.

PMID:
24667281
20.

Should beta-blockers form the cornerstone for the treatment of congestive heart failure?

Tabrizchi R.

Expert Rev Cardiovasc Ther. 2003 Jul;1(2):157-60. Review. No abstract available.

PMID:
15030275

Supplemental Content

Support Center